Luminex Corporation http://www.alacrastore.com/company-snapshot/Luminex_Corporation-2102676 Saturday, August 30, 2008 10:02:42 AM 2102676 Luminex Corporation en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/ccbn/T1904401ccbn/T1904401norm...Good day, everyone, and welcome everyone to the Luminex Second Quarter #### Earnings Conference Call. Today's call is being recorded. At this time, for opening remarks and introductions, I'd like to turn the call over to Mr. Harriss Currie. Please go ahead, sir. ... 8/7/2008 11:05:00 PMLuminex Corp54.0000FinalLuminex Corp Q2 2008 Earnings Conference Call TranscriptLMNX5:00pm ETTranscriptT1904401Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/newstex/BW-0001-26738075newstex/BW-0001-26738075xml Jul. ##, #### (Business Wire) -- Luminex Corporation (NASDAQ:LMNX) today announced that it expects to report second quarter results on Thursday, August #, ####. Results are scheduled for release after the close of trading. Management...040000000401600004016001040160480401601804003000040030051300000013002000130020057/17/2008 2:24:16 PM180000001800400018008000Business WireBW-0001-26738075LUMINEX CORPLMNXNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-26341017newstex/BW-0001-26341017xml Jun. ##, #### (Business Wire) -- Luminex Corporation (NASDAQ:LMNX) announced today the closing of its underwritten public offering of #,###,### shares of its common stock, including ###,### shares issued in connection with the underwriters...04000000040160000401601904002000040020061300000013002000130020056/30/2008 2:37:07 PM1800000018013000190000001900100019001032Business WireBW-0001-26341017LUMINEX CORPUBS AGLMNXUBSNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-26222348newstex/BW-0001-26222348xml Jun. ##, #### (Business Wire) -- Luminex Corporation (NASDAQ:LMNX) announced today the pricing of its underwritten public offering of #,###,### shares of its common stock. The Company has granted the underwriters a ##-day option to...04000000040160000401601904002000040020061300000013002000130020056/25/2008 10:19:40 AM1800000018013000190000001900100019001032Business WireBW-0001-26222348LUMINEX CORPUBS AGLMNXUBSNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T1827665ccbn/T1827665norm...Good day and welcome everyone to the Luminex First Quarter #### Earnings Conference Call. Today's call is being recorded. At this time, for opening remarks and introductions, I'd like to turn the call over to Mr. Harriss Currie. Please go ahead, sir. ... 5/9/2008 2:07:00 AMLuminex Corp54.0000FinalQ1 2008 Luminex Corp Earnings Conference Call TranscriptLMNX5:00pm ETTranscriptT1827665Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1802227ccbn/T1802227norm... - Leerink Swann - AnalystWe're going on. The next fireside chat presentation is with Luminex, a Company on which I write research for Leerink Swann. We are joined by Doug Bryant, who is the Chief Operating Officer of Luminex. He joined Luminex from Abbott. We are also joined by Harriss Currie, the Chief Financial Officer of Luminex. And we are going to take a few minutes and hopefully informally explore some of the issues for Luminex and some of the opportunities that the Company sees. Your questions are naturally welcome.We're just going to spend a couple of seconds going over the platform for a few minutes and then segue into the molecular diagnostics opportunity for Luminex and how they are approaching it. So, Doug, thanks for coming. Welcome. ... 4/3/2008 12:06:00 PMLuminex Corp54.0000FinalLuminex Corp at Leerink Molecular Diagnostics Roundtable Conference TranscriptLMNX10:50am ETTranscriptT1802227Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1783680ccbn/T1783680norm... - Luminex - President & CEO Good afternoon, everyone. Welcome to the Luminex Corporation annual investor event. My name is Pat Balthrop. I'm the CEO and President of the Company. Thank you for coming. Per regulation FD, we're web casting the event today and it will be available on our website. So, if you're attending by webcast, also welcome. And for those of you who are attending in person today, we'll have handouts of our slides available for you after the presentation. Our objective today is to provide you with information about the Company's priorities, market opportunities, and areas of focus and our plans to execute to drive long-term shareholder value. In order to accomplish this and to provide a sense of the leadership that will deliver the results, I've asked several of my colleagues to join me to discuss their respective areas of responsibility. We're excited to be with you today and to have the opportunity to provide you with an update regarding the progress that we're making.... 3/7/2008 9:05:00 PMLuminex Corp54.0000FinalLuminex Investor Day TranscriptLMNX12:00pm ETTranscriptT1783680Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1748700ccbn/T1748700normQ# #### Luminex Corp Earnings Conference Call2/7/2008 7:06:00 PMLuminex Corp54.0000FinalQ4 2007 Luminex Corp Earnings Conference Call TranscriptLMNX5:00pm ETTranscriptT1748700Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1737951ccbn/T1737951norm1/9/2008 3:05:00 PMLuminex Corp54.0000FinalLuminex Corp at JPMorgan Healthcare Conference TranscriptLMNX3:00pm PT... - Luminex Corporation - President, CEO My name is Pat Balthrop. I am the President and Chief Executive Officer of Luminex. I would like to start by expressing my appreciation to JPMorgan for another invitation to present to you at the conference this year. And what I want to do is take the next ## or ## minutes or so and talk to you about the Company, where we have come and also where we are going. Obviously associated with that we will be making some forward-looking statements today, and I would like you to refer to our public filings about the risks and uncertainties associated with those risks and uncertainties. Joining me today is Harriss Currie, our Chief Financial Officer. And after the presentation today Harris and I will be glad to take your questions during the breakout session. Luminex is the worldwide leader in multiplexing solutions for the life science research and diagnostic markets. We serve the market by way of a unique proprietary technology that we call xMAP technology.... TranscriptT1737951Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1668393ccbn/T1668393norm10/25/2007 10:09:00 AMLuminex Corp54.0000FinalQ3 2007 Luminex Corp Earnings Conference Call TranscriptLMNX8:00am ET...Good day and welcome to the Luminex third quarter #### Earnings Conference Call. Today's conference is being recorded. At this time for opening remarks and introductions, I would like to turn the call over to the Chief Financial Officer, Mr. Harriss Currie. Please go ahead, sir. ... TranscriptT1668393Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1657630ccbn/T1657630norm10/16/2007 1:04:00 PMLuminex Corp54.0000FinalLuminex Corp at Biotechnology Industry Organization Investor Forum TranscriptLMNX9:30am PT...Thank you everyone for coming. Our next presenting company is Luminex Corporation from Austin Texas and presenting is the President and CEO, Patrick Balthrop. ... TranscriptT1657630Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1652870ccbn/T1652870norm9/24/2007 4:06:00 PMLuminex Corp54.0000FinalLuminex Corp at America's Growth Capital Emerging Growth Conference TranscriptLMNX8:30am ET... - America's Growth Capital - Moderator/AnalystWell, good morning. I'd like to welcome you all to the -- this is the panel room and our first panel this morning is the life science tools panel. My name is Tony Klemmer. I'm a partner with America's Growth Capital. I lead the life science and health care practice. I'm going to introduce our panelists kind enough to join us today. They will comment then briefly on their companies, their perspective on the topics at hand, and then we will have a round of questions and we will open it up to all of you, so be thinking about your burning questions as we go. To my right that would be, Patrick Balthrop who leads Luminex, and David Green, the President of Harvard Bioscience, Kevin Hrusovsky who leads Caliper Life Sciences, and at the far end, last but not least, John Austin, President of Aushon BioSystems -- so three public companies and a private company. I will turn it over to Patrick to tell us a little bit more about Luminex. ... TranscriptT1652870Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/srp/-603408398srp/-603408398norm-60340839855027E102LMNX10/6/2006 12:38:00 PM-603408398Credit & Investment ResearchSharkRepellent.net